Suppr超能文献

肝细胞癌的诊断与治疗

[Diagnosis of and therapy for hepatocellular carcinoma].

作者信息

Greten T F, Malek N P, Schmidt S, Arends J, Bartenstein P, Bechstein W, Bernatik T, Bitzer M, Chavan A, Dollinger M, Domagk D, Drognitz O, Düx M, Farkas S, Folprecht G, Galle P, Geißler M, Gerken G, Habermehl D, Helmberger T, Herfarth K, Hoffmann R T, Holtmann M, Huppert P, Jakobs T, Keller M, Klempnauer J, Kolligs F, Körber J, Lang H, Lehner F, Lordick F, Lubienski A, Manns M P, Mahnken A, Möhler M, Mönch C, Neuhaus P, Niederau C, Ocker M, Otto G, Pereira P, Pott G, Riemer J, Ringe K, Ritterbusch U, Rummeny E, Schirmacher P, Schlitt H J, Schlottmann K, Schmitz V, Schuler A, Schulze-Bergkamen H, von Schweinitz D, Seehofer D, Sitter H, Straßburg C P, Stroszczynski C, Strobel D, Tannapfel A, Trojan J, van Thiel I, Vogel A, Wacker F, Wedemeyer H, Wege H, Weinmann A, Wittekind C, Wörmann B, Zech C J

出版信息

Z Gastroenterol. 2013 Nov;51(11):1269-326. doi: 10.1055/s-0033-1355841. Epub 2013 Nov 15.

Abstract

The interdisciplinary guidelines at the S3 level on the diagnosis of and therapy for hepatocellular carcinoma (HCC) constitute an evidence-and consensus-based instrument that is aimed at improving the diagnosis of and therapy for HCC since these are very challenging tasks. The purpose of the guidelines is to offer the patient (with suspected or confirmed HCC) adequate, scientifically based and up-to-date procedures in diagnosis, therapy and rehabilitation. This holds not only for locally limited or focally advanced disease but also for the existence of recurrences or distant metastases. Besides making a contribution to an appropriate health-care service, the guidelines should also provide the foundation for an individually adapted, high-quality therapy. The explanatory background texts should also enable non-specialist but responsible colleagues to give sound advice to their patients concerning specialist procedures, side effects and results. In the medium and long-term this should reduce the morbidity and mortality of patients with HCC and improve their quality of life.

摘要

S3级肝细胞癌(HCC)诊断与治疗的跨学科指南是一种基于证据和共识的工具,旨在改善HCC的诊断与治疗,因为这些任务极具挑战性。该指南的目的是为患者(疑似或确诊为HCC)提供在诊断、治疗和康复方面充分、科学且最新的程序。这不仅适用于局部局限或局部进展期疾病,也适用于复发或远处转移的情况。除了有助于提供适当的医疗服务外,该指南还应为个性化的高质量治疗奠定基础。解释性背景文本还应使非专科但负责的同事能够就专科程序、副作用和结果向患者提供合理建议。从中长期来看,这应降低HCC患者的发病率和死亡率,并改善他们的生活质量。

相似文献

1
[Diagnosis of and therapy for hepatocellular carcinoma].
Z Gastroenterol. 2013 Nov;51(11):1269-326. doi: 10.1055/s-0033-1355841. Epub 2013 Nov 15.
2
[National S3 guidelines on hepatocellular carcinoma].
Radiologe. 2014 Jul;54(7):642-53. doi: 10.1007/s00117-014-2656-0.
3
[Hepatocellular carcinoma: An interdisciplinary challenge].
Radiologe. 2014 Jul;54(7):641. doi: 10.1007/s00117-014-2649-z.
4
In reply.
Dtsch Arztebl Int. 2014 Jun 27;111(26):464. doi: 10.3238/arztebl.2014.0464b.
5
SIRT was given short shrift.
Dtsch Arztebl Int. 2014 Jun 27;111(26):464. doi: 10.3238/arztebl.2014.0464a.
7
[Operative therapy of hepatocellular carcinoma].
Radiologe. 2014 Jul;54(7):673-8. doi: 10.1007/s00117-014-2653-3.
8
The diagnosis and treatment of hepatocellular carcinoma.
Dtsch Arztebl Int. 2014 Feb 14;111(7):101-6. doi: 10.3238/arztebl.2014.0101.
9
Changes in and challenges regarding the surgical treatment of hepatocellular carcinoma in China.
Biosci Trends. 2021 Jul 6;15(3):142-147. doi: 10.5582/bst.2021.01083. Epub 2021 Mar 14.
10
Hepatocellular carcinoma.
Br J Cancer. 2001 May;84 Suppl 2(Suppl 2):74-7. doi: 10.1054/bjoc.2001.1769.

引用本文的文献

2
Use of machine learning models for the prognostication of liver transplantation: A systematic review.
World J Transplant. 2024 Mar 18;14(1):88891. doi: 10.5500/wjt.v14.i1.88891.
3
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors.
Int J Mol Sci. 2023 May 10;24(10):8548. doi: 10.3390/ijms24108548.
4
[Intersectoral management of patients with abnormal liver enzymes and non-alcoholic fatty liver disease (NAFLD)].
Z Gastroenterol. 2023 Aug;61(8):1028-1036. doi: 10.1055/a-1957-5671. Epub 2023 Feb 15.
6
Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A Narrative Review.
Visc Med. 2022 Apr;38(2):126-132. doi: 10.1159/000519611. Epub 2021 Oct 26.
7
[Local and locoregional treatment of intrahepatic cholangiocarcinoma].
Radiologe. 2022 Mar;62(3):247-252. doi: 10.1007/s00117-021-00946-9. Epub 2022 Jan 3.
9
Early Detection of Hepatocellular Carcinoma Since the Introduction of the German Clinical Practice Guideline in 2013.
Dtsch Arztebl Int. 2021 Aug 9;118(31-32):540-541. doi: 10.3238/arztebl.m2021.0232.

本文引用的文献

6
Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis.
J Clin Endocrinol Metab. 2012 Jul;97(7):2347-53. doi: 10.1210/jc.2012-1267. Epub 2012 Apr 20.
7
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.
J Hepatol. 2012 Jul;57(1):167-85. doi: 10.1016/j.jhep.2012.02.010. Epub 2012 Mar 20.
8
[Paradigmatic change in treatment of viral hepatitides].
Dtsch Med Wochenschr. 2012 Mar;137(13):640-3. doi: 10.1055/s-0031-1298980. Epub 2012 Mar 20.
9
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.
J Hepatol. 2012 Apr;56(4):908-43. doi: 10.1016/j.jhep.2011.12.001.
10
Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma.
J Hepatol. 2012 Jul;57(1):101-7. doi: 10.1016/j.jhep.2012.02.016. Epub 2012 Mar 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验